Literature DB >> 15117763

Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation.

Kristina M Adams1, Leona A Holmberg, Wendy Leisenring, Alexander Fefer, Katherine A Guthrie, Tracy S Tylee, George B McDonald, William I Bensinger, J Lee Nelson.   

Abstract

Syngeneic graft-versus-host disease (sGVHD) has been described after hematopoietic cell transplantation (HCT) but remains poorly defined. We retrospectively reviewed adult syngeneic HCTs at our center (1980-2002) for sGVHD to investigate incidence, morbidity, and risk factors with a primary focus on parity. Among 119 transplantations, there were 21 cases of biopsy-proven sGVHD. The cumulative incidence was 18%, with multiorgan involvement in 6 cases and 1 death. sGVHD was more frequent when the donor was parous (32%) than nulliparous (9%) or male (13%; P =.03) and when the recipient was parous (31%) than nulliparous (7%) or male (13%; P =.02). Other univariable risk factors included older age (P <.01), busulfan/melphalan/thiotepa conditioning (P <.01), interleukin-2 (P =.02), HLA-A26 (P =.03), and more recent transplantation year (P <.01). Overall, risk factors were similar to those described in GVHD. Although an independent effect of parity could not be completely separated from other factors, donor and recipient pregnancy history merits further investigation.

Entities:  

Mesh:

Year:  2004        PMID: 15117763     DOI: 10.1182/blood-2004-02-0508

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus.

Authors:  Olivia J Holland; Caitlin Linscheid; Herbert C Hodes; Traci L Nauser; Melissa Gilliam; Peter Stone; Larry W Chamley; Margaret G Petroff
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

Review 2.  Naturally acquired microchimerism: implications for transplantation outcome and novel methodologies for detection.

Authors:  Michael Eikmans; Astrid G S van Halteren; Koen van Besien; Jon J van Rood; Jos J M Drabbels; Frans H J Claas
Journal:  Chimerism       Date:  2014

3.  Late recurrence of autologous GvHD in a myeloma patient: a myth or diagnostic challenge?

Authors:  N El-Jurdi; M Ueda; L Jia; H Lazarus
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

4.  Autologous GVHD?

Authors:  F Otegbeye; R P Gale; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2014-08-04       Impact factor: 5.483

Review 5.  B cells in chronic graft-versus-host disease.

Authors:  William McManigle; Ayman Youssef; Stefanie Sarantopoulos
Journal:  Hum Immunol       Date:  2019-03-05       Impact factor: 2.850

6.  Immune response to a model shared placenta/tumor-associated antigen reduces cancer risk in parous mice.

Authors:  Susmita Jasti; Mina Farahbakhsh; Sean Nguyen; Brian K Petroff; Margaret G Petroff
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

Review 7.  Naturally acquired microchimerism.

Authors:  Hilary S Gammill; J Lee Nelson
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

8.  Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation.

Authors:  Fa-Hong Yan; Mei Wang; Jian-Feng Yao; Er-Lie Jiang; Ming-Zhe Han
Journal:  Chin Med J (Engl)       Date:  2017-06-05       Impact factor: 2.628

9.  Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation.

Authors:  Yöntem Yaman; Gökhan Baysoy; Emre Keleşoğlu; Kürşat Özdilli; Aslı Çakır; Dildar Bahar Genç; Murat Elli; Sema Anak
Journal:  Contemp Oncol (Pozn)       Date:  2019-03-25

10.  Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis.

Authors:  Shuhei Kurosawa; Shohei Mizuno; Yasuyuki Arai; Masayoshi Masuko; Junya Kanda; Kentaro Kohno; Daishi Onai; Takahiro Fukuda; Yukiyasu Ozawa; Yuta Katayama; Masatsugu Tanaka; Kazuhiro Ikegame; Naoyuki Uchida; Tetsuya Eto; Shuichi Ota; Junji Tanaka; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada
Journal:  Blood Cancer J       Date:  2021-09-24       Impact factor: 11.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.